Dr. Sofie Ryckx
ActiveSummary
Dr. Sofie Ryckx has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €114,970 and a net result of €95,679. Equity is growing by about 40% per year across the filed financial years. Its solvency ranks better than 88% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2018 to 2025net €114,289 ▲76.6%
Operating result €146,303, net result €114,289, both a record.
25-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Equity above €200,000equity €217,002 ▲48.5%
5 profitable years in a row build equity to €217,002.
29-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Equity above €100,000equity €146,097 ▲74.9%
4 profitable years in a row build equity to €146,097.
29-06
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
29-06
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
30-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
31-12
Financial
Back to profitnet €43,947
Net result €43,947 after one loss-making year.
31-12
Financial
Liquidity more than 24 timescurrent ratio 38.35
Current ratio from 1.57 to 38.35; short-term debt falls from €10,214 to €1,377.
28-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.